182
Participants
Start Date
December 30, 2021
Primary Completion Date
March 1, 2026
Study Completion Date
March 1, 2029
Hypofractionated radiotherapy for low- and intermediate-risk prostate cancer patients
Hypofractionated radiotherapy for low- and intermediate-risk prostate cancer will be treated with 20x3 Gray (Gy), 5 days/week
Hypofractionated radiotherapy for high-risk prostate cancer patients
Hypofractionated radiotherapy for high-risk prostate cancer will be treated with 20x3.1 Gy, 5 days/week
NSIA-LUTH Cancer Center, Lagos
Inkosi Albert Luthuli Central Hospital, Durban
Ocean Road Cancer Institute, Dar es Salaam
Collaborators (1)
Inkosi Albert Luthuli Central Hospital
UNKNOWN
Erasmus Medical Center
OTHER
Dana-Farber Cancer Institute
OTHER
Nigeria Sovereign Investment Authority-Lagos University Teaching Hospital Cancer Center (NLCC)
UNKNOWN
Muhimbili University of Health and Allied Sciences
OTHER